Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Robert P. Fuchs"'
Autor:
Shingo Fujii, Robert P. Fuchs
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8192 (2024)
In clinics, chemotherapy is often combined with surgery and radiation to increase the chances of curing cancers. In the case of glioblastoma (GBM), patients are treated with a combination of radiotherapy and TMZ over several weeks. Despite its common
Externí odkaz:
https://doaj.org/article/bff9d94038a843c5b8626c945674587d
Publikováno v:
DNA, Vol 3, Iss 2, Pp 109-118 (2023)
Human genomic DNA contains a number of diverse repetitive sequence motifs, often identified as fragile sites leading to genetic instability. Among them, expansion events occurring at triplet repeats have been extensively studied due to their associat
Externí odkaz:
https://doaj.org/article/653e6380f8884c1dbe82b81cc481a35f
Publikováno v:
STAR Protocols, Vol 2, Iss 2, Pp 100399- (2021)
Summary: Translesion synthesis (TLS) is an event to cope with DNA damages. During TLS, the responsible TLS polymerase frequently elicits untargeted mutagenesis as potentially a source of genetic diversity. Identifying such untargeted mutations in viv
Externí odkaz:
https://doaj.org/article/ebd7338c665b4d328ac104b470d4ba0c
Autor:
Robert P Fuchs, Asako Isogawa, Joao A Paulo, Kazumitsu Onizuka, Tatsuro Takahashi, Ravindra Amunugama, Julien P Duxin, Shingo Fujii
Publikováno v:
eLife, Vol 10 (2021)
Temozolomide (TMZ), a DNA methylating agent, is the primary chemotherapeutic drug used in glioblastoma treatment. TMZ induces mostly N-alkylation adducts (N7-methylguanine and N3-methyladenine) and some O6-methylguanine (O6mG) adducts. Current models
Externí odkaz:
https://doaj.org/article/0d670b1a8f304282bd6a3a696de67cd0
Publikováno v:
DNA; Volume 3; Issue 2; Pages: 109-118
Human genomic DNA contains a number of diverse repetitive sequence motifs, often identified as fragile sites leading to genetic instability. Among them, expansion events occurring at triplet repeats have been extensively studied due to their associat
Processing closely spaced lesions during Nucleotide Excision Repair triggers mutagenesis in E. coli.
Publikováno v:
PLoS Genetics, Vol 13, Iss 7, p e1006881 (2017)
It is generally assumed that most point mutations are fixed when damage containing template DNA undergoes replication, either right at the fork or behind the fork during gap filling. Here we provide genetic evidence for a pathway, dependent on Nucleo
Externí odkaz:
https://doaj.org/article/33be63b4cdeb4c44bfa6ad512142559c
Publikováno v:
DNA Repair
DNA Repair, 2022, 112, pp.103303. ⟨10.1016/j.dnarep.2022.103303⟩
DNA Repair, 2022, 112, ⟨10.1016/j.dnarep.2022.103303⟩
DNA Repair (Amst)
DNA Repair, 2022, 112, pp.103303. ⟨10.1016/j.dnarep.2022.103303⟩
DNA Repair, 2022, 112, ⟨10.1016/j.dnarep.2022.103303⟩
DNA Repair (Amst)
International audience; The cellular response to alkylation damage is complex, involving multiple DNA repair pathways and checkpoint proteins, depending on the DNA lesion, the cell type, and the cellular proliferation state. The repair of and respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037485700e93b5ef509b318bc3087ac0
https://hal.science/hal-03813433/document
https://hal.science/hal-03813433/document
Publikováno v:
PLoS Genetics, Vol 11, Iss 12, p e1005757 (2015)
DNA Damage Tolerance (DDT) mechanisms help dealing with unrepaired DNA lesions that block replication and challenge genome integrity. Previous in vitro studies showed that the bacterial replicase is able to re-prime downstream of a DNA lesion, leavin
Externí odkaz:
https://doaj.org/article/9915441300cf446daed0db6f5f7fb753
Autor:
Joao A. Paulo, Kazumitsu Onizuka, Shingo Fujii, Asako Isogawa, Robert P Fuchs, Julien P. Duxin, Ravindra Amunugama, Tatsuro S. Takahashi
Publikováno v:
eLife
eLife, eLife Sciences Publication, 2021, 10, ⟨10.7554/eLife.69544⟩
eLife, 2021, 10, ⟨10.7554/eLife.69544⟩
eLife, Vol 10 (2021)
Fuchs, R P, Isogawa, A, Paulo, J A, Onizuka, K, Takahashi, T, Amunugama, R, Duxin, J P & Fujii, S 2021, ' Crosstalk between repair pathways elicits Double Strand Breaks in alkylated DNA and implications for the action of temozolomide ', eLife, vol. 10, e69544 . https://doi.org/10.7554/eLife.69544
eLife, eLife Sciences Publication, 2021, 10, ⟨10.7554/eLife.69544⟩
eLife, 2021, 10, ⟨10.7554/eLife.69544⟩
eLife, Vol 10 (2021)
Fuchs, R P, Isogawa, A, Paulo, J A, Onizuka, K, Takahashi, T, Amunugama, R, Duxin, J P & Fujii, S 2021, ' Crosstalk between repair pathways elicits Double Strand Breaks in alkylated DNA and implications for the action of temozolomide ', eLife, vol. 10, e69544 . https://doi.org/10.7554/eLife.69544
Temozolomide (TMZ), a DNA methylating agent, is the primary chemotherapeutic drug used in glioblastoma treatment. TMZ induces mostly N-alkylation adducts (N7-methylguanine and N3-methyladenine) and some O6-methylguanine (O6mG) adducts. Current models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a20ea5955c4ee02a7ff8f68f31f373cf
https://hal.archives-ouvertes.fr/hal-03373140
https://hal.archives-ouvertes.fr/hal-03373140